Promising Manufacturing Stocks Worth Watching – April 7th

by · The Cerbat Gem

Taiwan Semiconductor Manufacturing, Applied Materials, and Astrazeneca are the three Manufacturing stocks to watch today, according to MarketBeat’s stock screener tool. Manufacturing stocks are shares of publicly traded companies whose primary business is producing physical goods in factories—examples include automakers, machinery makers, electronics manufacturers, and chemical producers. For investors, these stocks are often cyclical and sensitive to economic growth, commodity and labor costs, supply‑chain conditions, and trade policy, so they tend to show stronger performance in expansions and greater volatility during downturns. These companies had the highest dollar trading volume of any Manufacturing stocks within the last several days.

Taiwan Semiconductor Manufacturing (TSM)

Taiwan Semiconductor Manufacturing Company Limited, together with its subsidiaries, manufactures, packages, tests, and sells integrated circuits and other semiconductor devices in Taiwan, China, Europe, the Middle East, Africa, Japan, the United States, and internationally. It provides a range of wafer fabrication processes, including processes to manufacture complementary metal- oxide-semiconductor (CMOS) logic, mixed-signal, radio frequency, embedded memory, bipolar CMOS mixed-signal, and others.

Read Our Latest Research Report on TSM

Applied Materials (AMAT)

Applied Materials, Inc. engages in the provision of manufacturing equipment, services, and software to the semiconductor, display, and related industries. The company operates through three segments: Semiconductor Systems, Applied Global Services, and Display and Adjacent Markets. The Semiconductor Systems segment develops, manufactures, and sells various manufacturing equipment that is used to fabricate semiconductor chips or integrated circuits.

Read Our Latest Research Report on AMAT

Astrazeneca (AZN)

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/Xigduo XR for cardiovascular, renal, and metabolism diseases; Bevespi Aerosphere, Breztri Aerosphere, Daliresp/Daxas, Duaklir Genuair, Fasenra, Pulmicort, Saphnelo, Symbicort, and Tudorza/Eklira/Bretaris for respiratory and immunology; and Andexxa/Ondexxya, Kanuma, Soliris, Strensiq, and Ultomiris for rare diseases.

Read Our Latest Research Report on AZN

See Also